This study comprehensively demonstrates the important roles of each lipid component in determining the in vivo fate of LNPs, guiding the rational design of next-generation LNP-based mRNA delivery systems.
Abstract
Lipid nanoparticles (LNPs) have represented a leading platform for mRNA delivery and therapeutics. While extensive studies have focused on optimizing ionizable lipids, the specific roles of helper lipids such as cholesterol, phospholipid, and polyethylene glycol lipid (PEG-lipid) remain relatively poorly understood. To elucidate the distinct contributions of individual lipid components, we reengineer LNP formulations by selectively removing each lipid component, especially helper lipids, to systematically analyze their effects on physicochemical properties, in vivo mRNA delivery, and inflammatory responses. Results reveal that ionizable lipid plays a critical role in mRNA delivery efficacy. Cholesterol is essential for efficient liver-targeted delivery but dispensable for extrahepatic delivery. Phospholipid is not directly associated with organ tropism, whereas phospholipid-free LNPs significantly alleviate inflammation. PEG-lipid influences particle size, with PEG-lipid-free LNPs exhibiting preferential spleen tropism. This study comprehensively demonstrates the important roles of each lipid component in determining the in vivo fate of LNPs, guiding the rational design of next-generation LNP-based mRNA delivery systems.
This review summarizes bioactive LNPs incorporating naturally sourced bioactive lipids, bioactive agent-derived lipids, or novel bioactive lipids identified through combinatorial synthesis coupled with high-throughput screening and provides perspectives on the challenges and opportunities in translating bioactive lipid...
Kaiqi Long, Jeffrey Yuan, Yang Zhang et al.· Materials Today· 0 citations
This study develops a class of ionizable cholesterol derivatives by conjugating biocompatible dimethylated amino acids to cholesterol through a cleavable linker, thereby integrating the structural role of cholesterol and the pH‐responsive ionization of ions into a single molecule.
Lipid nanoparticles (LNPs) are the most advanced non-viral platform for hepatic mRNA delivery, yet the functional role of helper phospholipids, particularly under repeated dosing regimens required for chronic protein replacement therapies, remains poorly understood. Here, we systematically investigated six helper phosp...
Key factors that link PEG-lipid composition and nanoparticle architecture to desorption kinetics and biological outcomes are identified and provide guidance for the design of PEGylated nanomaterials with improved control over interfacial stability, immune recognition, and functional performance.
Ethan P. Cisneros, Aadya S. Wijesekera, Lisa R. Volpatti· Small· 0 citations
Lipid nanoparticles (LNPs) preferentially accumulate in the liver, but hepatic tropism alone does not ensure productive RNA interference. Here, we screened a library of LNPs in which lipid composition was varied to generate distinct protein corona identities and identify formulations capable of combining liver accumula...
N. G. Sukubo, Serena Renzi, M. Violatto et al.· Small· 0 citations
Lipid nanoparticles (LNPs) are the leading platform for RNA delivery, enabling applications ranging from mRNA vaccines to CRISPR therapeutics. Ionizable lipids, such as DLin-MC3-DMA (MC3), play a central role in nucleic acid encapsulation and intracellular delivery, yet the molecular mechanisms governing LNP structur...
Xiao-Bing Chen, Cong Xu, Carlos R. Baiz· Journal of Physical Chemistr...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.